BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16696917)

  • 21. [The study on the anti-oxidation effect of root of Mallotus apelta in the rat model of liver fibrosis].
    Zhao J; Lü Z; Wang X; Zhang X
    Zhong Yao Cai; 2002 Mar; 25(3):185-7. PubMed ID: 12583162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives for the treatment of hepatitis B virus infections.
    De Clercq E
    Int J Antimicrob Agents; 1999 Jul; 12(2):81-95. PubMed ID: 10418752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
    Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
    Chen G; Chen J; Liu D; Zhang X; Zhu C; Li Y; Wang L; Yang Y; Cai G; Han F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):329-32. PubMed ID: 15617240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
    Chen X; Chen H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):277-81. PubMed ID: 15617348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
    Ying C; Tan S; Cheng YC
    Antivir Chem Chemother; 2010; 21(2):97-103. PubMed ID: 21107018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo.
    Zhou Z; Zhang Y; Ding XR; Chen SH; Yang J; Wang XJ; Jia GL; Chen HS; Bo XC; Wang SQ
    Antiviral Res; 2007 Apr; 74(1):59-64. PubMed ID: 17298850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense therapy of hepatitis B virus infection.
    Offensperger WB; Offensperger S; Blum HE
    Mol Biotechnol; 1998 Apr; 9(2):161-70. PubMed ID: 9658393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-hepatitis B virus activities of triterpenoid saponin compound from Potentilla anserine L.
    Zhao YL; Cai GM; Hong X; Shan LM; Xiao XH
    Phytomedicine; 2008 Apr; 15(4):253-8. PubMed ID: 18337074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
    Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
    Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
    J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN; Slomka MJ; Maung M
    J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
    Foster WK; Miller DS; Scougall CA; Kotlarski I; Colonno RJ; Jilbert AR
    J Virol; 2005 May; 79(9):5819-32. PubMed ID: 15827196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
    Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
    Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L.
    Liu S; Wei W; Shi K; Cao X; Zhou M; Liu Z
    J Ethnopharmacol; 2014 Sep; 155(2):1061-7. PubMed ID: 25009077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
    Le Guerhier F; Pichoud C; Guerret S; Chevallier M; Jamard C; Hantz O; Li XY; Chen SH; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2000 Jan; 44(1):111-22. PubMed ID: 10602731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
    Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
    Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo.
    Li CQ; Zhu YT; Zhang FX; Fu LC; Li XH; Cheng Y; Li XY
    World J Gastroenterol; 2005 Jan; 11(3):426-8. PubMed ID: 15637760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.